Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Роль цефалоспоринов в терапии воспалительных заболеваний органов малого таза
Роль цефалоспоринов в терапии воспалительных заболеваний органов малого таза
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Cho N, Fukunaga K, Kunii K, Kimura T. 7432-S in the obstetric and gynecological field. Chemotherapy 1989; 37 (Suppl.): 570–8.
2. Yamamoto T, Yasuda J, Kanao M, Okada H. Basic and clinical studies on 7432-S in the obstetric and gynecological field. Chemotherapy 1989; 37 (Suppl.): 600–6.
3. Matsuda S, Shimizu T, Maki M et al. Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections. Chemotherapy 1989; 37 (Suppl.): 667–700.
4. Wiseman LR, Balfour JA. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47 (5): 784–808.
5. Perilli M, Segatore B, Franceschini N et al. Устойчивость Цефтибутена к сериновым и металло-β-лактамазам. 2001.
6. Neu HC. Ceftibuten: Minimal inhibitory concentration – postantibiotic effect on beta-lactamase stability – a rational dosing programmes. Pediatr Infect Dis J 1993; 12: 49–55.
7. New Global Survey Shows Most People Are Concerned About Antibiotic Resistance But Many Don't Link Problem With Improper Use of Medicines.
2. Yamamoto T, Yasuda J, Kanao M, Okada H. Basic and clinical studies on 7432-S in the obstetric and gynecological field. Chemotherapy 1989; 37 (Suppl.): 600–6.
3. Matsuda S, Shimizu T, Maki M et al. Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections. Chemotherapy 1989; 37 (Suppl.): 667–700.
4. Wiseman LR, Balfour JA. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47 (5): 784–808.
5. Perilli M, Segatore B, Franceschini N et al. Устойчивость Цефтибутена к сериновым и металло-β-лактамазам. 2001.
6. Neu HC. Ceftibuten: Minimal inhibitory concentration – postantibiotic effect on beta-lactamase stability – a rational dosing programmes. Pediatr Infect Dis J 1993; 12: 49–55.
7. New Global Survey Shows Most People Are Concerned About Antibiotic Resistance But Many Don't Link Problem With Improper Use of Medicines.
2. Yamamoto T, Yasuda J, Kanao M, Okada H. Basic and clinical studies on 7432-S in the obstetric and gynecological field. Chemotherapy 1989; 37 (Suppl.): 600–6.
3. Matsuda S, Shimizu T, Maki M et al. Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections. Chemotherapy 1989; 37 (Suppl.): 667–700.
4. Wiseman LR, Balfour JA. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47 (5): 784–808.
5. Perilli M, Segatore B, Franceschini N et al. Устойчивость Цефтибутена к сериновым и металло-β-лактамазам. 2001.
6. Neu HC. Ceftibuten: Minimal inhibitory concentration – postantibiotic effect on beta-lactamase stability – a rational dosing programmes. Pediatr Infect Dis J 1993; 12: 49–55.
7. New Global Survey Shows Most People Are Concerned About Antibiotic Resistance But Many Don't Link Problem With Improper Use of Medicines.
________________________________________________
2. Yamamoto T, Yasuda J, Kanao M, Okada H. Basic and clinical studies on 7432-S in the obstetric and gynecological field. Chemotherapy 1989; 37 (Suppl.): 600–6.
3. Matsuda S, Shimizu T, Maki M et al. Comparative double-blind clinical trial of ceftibuten (7432-S) and bacampicillin (BAPC) against gynecological infections. Chemotherapy 1989; 37 (Suppl.): 667–700.
4. Wiseman LR, Balfour JA. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47 (5): 784–808.
5. Perilli M, Segatore B, Franceschini N et al. Устойчивость Цефтибутена к сериновым и металло-β-лактамазам. 2001.
6. Neu HC. Ceftibuten: Minimal inhibitory concentration – postantibiotic effect on beta-lactamase stability – a rational dosing programmes. Pediatr Infect Dis J 1993; 12: 49–55.
7. New Global Survey Shows Most People Are Concerned About Antibiotic Resistance But Many Don't Link Problem With Improper Use of Medicines.
Авторы
А.Л.Тихомиров, С.И.Сарсания, Т.В.Деды, В.Г.Абышева
Кафедра акушерства и гинекологии лечебного факультета МГМСУ (зав. – проф. И.Б.Манухин)
Кафедра акушерства и гинекологии лечебного факультета МГМСУ (зав. – проф. И.Б.Манухин)
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.